Project Grant R01HL180694
Award Date 9/10/25
Completion Date 5/31/29
Dollars Obligated $773K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
- This federal Project Grant award, totaling $119,084, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The primary objective of this 2-year project (7/15/2025 - 6/30/2027) is to quantify the risk of congenital malformations in infants associated with in utero exposure during the first trimester to certain cardiometabolic medications, including angiotensin-converting enzyme...
- This $275,196 federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research at the University of Chicago investigating the impact of adolescent reproductive health factors on the risk of cardiometabolic disease in young adult women. The project aims to analyze longitudinal data from the Pittsburgh Girls Study to examine associations between adolescent pubertal development, sexual health, and pregnancy history with...
- This federal Project Grant award for $696,470, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to investigate the relationship between prenatal maternal sleep and cardiovascular disease risk in offspring. The University of Denver is the primary awardee, and they have sub-awards with Northwestern University and the University of Colorado, Anschutz Medical Center. The key objectives are to: 1) examine how prenatal maternal sleep...
- This Project Grant award from the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $115,000.00 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to investigate the potential role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in improving cardiovascular and kidney outcomes for patients with Systemic Lupus Erythematosus (SLE) and Lupus Nephritis. The...
- This $802,363 federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a research study at Emory University from September 2025 to June 2030 to develop models for predicting the benefits of GLP-1 receptor agonist (GLP-1RA) treatments in preventing obesity-related cardiometabolic diseases. The study aims to use clinical...
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded a $107,834 project grant to The Leland Stanford Junior University. The grant, which runs from January 21, 2025 to January 2, 2026, aims to investigate the cardiovascular impact of novel gut-hormone agonists, including semaglutide (GLP-1R), tirzepatide (GLP-1R/GIPR), and retatrutide (GLP-1R/GIPR/GCGR). The research will involve comprehensive profiling of...
- This federal Project Grant award was provided by the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), to study the determinants of postpartum contraception and inter-pregnancy intervals. The total award amount is $1,371,278.00, with a project period from March 1, 2025 to November 30, 2029. The key objectives of this research project are to examine patient, partner, and provider factors that...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop and pilot an electronic health record-based physical activity intervention to prevent progression of postpartum hypertension in women with subclinical blood pressure elevations during pregnancy. The $192,199 grant awarded to Northwestern University will fund a 5-year project focused on (1) identifying factors that influence...
- This Project Grant award of $226,608.00 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is funding research to identify the mechanistic link between fetal glucagon and placental nutrient delivery. The goal is to establish how fetal glucagon regulates placental lactogen secretion and uterine blood flow as an adaptive mechanism for matching nutrient supply to...
- This Project Grant award of $751,124 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Kaiser Foundation Hospitals supports research focused on the prevention of hypertensive disorders of pregnancy (HDP), which affect 10-15% of pregnancies and are risk factors for future cardiovascular disease in women. The key objectives are to explore the timing and intensity of physical activity, as well as the optimal 24-hour activity composition including...